| Name | Title | Contact Details |
|---|
O2 Concepts has reimagined non-delivery, stepping forward as the first manufacturer to create a smart POC integrated over the Verizon Network that benefits dealers and patients alike. Dynamic Network Analysis (DNA) allows oxygen providers to monitor all devices remotely for location, usage and performance, as well as troubleshoot to prevent any unnecessary dispatches. DNA Technology™ serves as an additional upgrade to 24/7 reliability and the Oxlife Independence`s standard 5 year warranty. O2 Concepts is privately held with factory operations in Newtown, CT and all products are proudly made in the USA.
Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.
Novare Surgical Systems is a Cupertino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
KYTOGENICS is a Chatham, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vascular Insights is a Quincy, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.